NASDAQ:MLNT - Melinta Therapeutics Price Target & Analyst Ratings

$3.98
+0.11 (+2.84 %)
(As of 07/22/2019 04:00 PM ET)
Today's Range
$3.87
Now: $3.98
$4.11
50-Day Range
$1.67
MA: $4.31
$7.89
52-Week Range
$1.62
Now: $3.98
$30.00
Volume545,700 shs
Average Volume1.44 million shs
Market Capitalization$46.88 million
P/E RatioN/A
Dividend YieldN/A
Beta4.31

Analyst Ratings

Melinta Therapeutics (NASDAQ:MLNT) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
7 Wall Street analysts have issued ratings and price targets for Melinta Therapeutics in the last 12 months. Their average twelve-month price target is $32.10, suggesting that the stock has a possible upside of 706.53%. The high price target for MLNT is $70.00 and the low price target for MLNT is $5.00. There are currently 2 sell ratings, 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldBuyBuy
Consensus Rating Score: 2.142.142.862.86
Ratings Breakdown: 2 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
2 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $32.10$32.10$62.9167$62.9167
Price Target Upside: 706.53% upside506.81% upside6,038.21% upside6,038.21% upside

Melinta Therapeutics (NASDAQ:MLNT) Consensus Price Target History

Melinta Therapeutics (NASDAQ:MLNT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
7/18/2019HC WainwrightReiterated RatingBuy$13.00HighView Rating Details
6/20/2019GabelliReiterated RatingSellLowView Rating Details
6/20/2019WBB SecuritiesDowngradeSpeculative Buy ➝ HoldHighView Rating Details
6/19/2019Cantor FitzgeraldSet Price TargetBuy$15.00LowView Rating Details
6/14/2019JPMorgan Chase & Co.DowngradeNeutral ➝ UnderweightHighView Rating Details
5/10/2019Jefferies Financial GroupDowngradeBuy ➝ Hold$14.00 ➝ $5.00HighView Rating Details
12/18/2018LADENBURG THALM/SH SHReiterated RatingBuy ➝ Buy$70.00HighView Rating Details
5/9/2018Robert W. BairdUpgradeNeutral ➝ OutperformHighView Rating Details
8/10/2017Roth CapitalDowngradeBuy ➝ Neutral$40.00 ➝ $20.00HighView Rating Details
8/10/2017Stifel NicolausReiterated RatingHold$20.00HighView Rating Details
(Data available from 7/22/2017 forward)
This page was last updated on 7/22/2019 by MarketBeat.com Staff

Featured Article: Economic Reports

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel